Person

Adam H. Schechter

Director, DaVita

Current S&P 500 boards
2
Current roles
2
Open-market buys
$0
Open-market sales
$68.2M

Current roles

From Section 16 filings (Forms 3, 4 and 5) in the last 13 months.

Past roles

“Last filing” is the latest Form 3/4/5 for that company, an upper bound on the end date.

  • MRK
    Merck & Co.
    EVP & Pres-Global Human Health
    2016 or earlier – last filing Nov 2018

Sits alongside

People who currently share a board or management team with this person.

Open-market trades

Purchases and sales reported on Form 4 at S&P 500 companies.

DateCompanyTypeSharesPriceValue
Aug 11, 2026LHSale4,669$320.37$1.5M
May 11, 2026LHSale5,903$254.50$1.5M
Mar 3, 2026LHSale8,705$279.96$2.4M
Feb 11, 2026LHSale5,273$284.38$1.5M
Nov 11, 2025LHSale5,745$262.75$1.5M
Aug 11, 2025LHSale5,643$266.78$1.5M
May 12, 2025LHSale6,105$248.73$1.5M
Feb 11, 2025LHSale6,121$244.62$1.5M
Nov 11, 2024LHSale6,189$243.47$1.5M
Nov 1, 2018MRKSale132,744$73.98$9.8M
Nov 1, 2018MRKSale145,135$73.66$10.7M
Sep 17, 2018MRKSale100,000$70.18$7.0M
Sep 17, 2018MRKSale7,360$70.18$517K
Jun 18, 2018MRKSale34,094$61.00$2.1M
Jun 18, 2018MRKSale100,000$61.00$6.1M
Feb 8, 2018LHSale1,263$169.29$214K
Jan 16, 2018MRKSale50,994$61.63$3.1M
Jan 16, 2018MRKSale50,608$61.63$3.1M
Apr 3, 2017MRKSale53,850$63.48$3.4M
Feb 3, 2017MRKSale36,335$63.73$2.3M
Sep 1, 2016MRKSale39,200$62.61$2.5M
Jul 1, 2016MRKSale50,000$57.69$2.9M

SEC reporting-owner ID (CIK) 1376841 · all filings on EDGAR